Search

alt
0500

FiltersClear filters

Status
Sex
Age

Pfizer clinical trials

Search Results

We found 146 clinical trials for: 150 miles

Recruiting
A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)
  • Recruiting
NCT06215118
Sex: All
Age: 18+
Locations: 43
View study
Recruiting
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
  • Recruiting
NCT05355701
Sex: All
Age: 16+
Locations: 41
View study
Recruiting
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
  • Recruiting
NCT05020236
Sex: All
Age: 18+
Locations: 238
View study
Recruiting
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
  • Recruiting
NCT06629779
Sex: Male
Age: 18+
Locations: 240
View study
Recruiting
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
  • Recruiting
NCT06679140
Sex: All
Age: 12+
Locations: 236
View study
Recruiting
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
  • Recruiting
NCT06989437
Sex: All
Age: 18+
Locations: 91
View study
Recruiting
A Study to Learn About the Study Medicine Aztreonam-Avibactam (ATM-AVI) in Infants and Newborns Admitted in Hospitals With Bacterial Infection (CHERISH)
  • Recruiting
NCT06462235
Sex: All
Age: Up to 39 weeks
Locations: 30
View study
Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
  • Recruiting
NCT04649242
Sex: All
Age: 6 - 17
Locations: 245
View study
Recruiting
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
  • Recruiting
NCT06966453
Sex: All
Age: 18+
Locations: 159
View study
Recruiting
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
  • Recruiting
NCT06152575
Sex: All
Age: 18+
Locations: 277
View study
...